Tirzepatide app engagement tied to 4.7-point weight-loss gap at six months

The wire

1. 01A retrospective cohort in Medicina clustered 9,470 medication-adherent tirzepatide initiators in a British digital weight-loss service, finding adjusted six-month weight-loss differences of 4.60% for high coach engagement and 4.69% for high chatbot engagement versus low engagement.
2. 02Telehealth operators pairing incretin prescribing with digital support can point to measured differences between passive self-trackers, conversational users and non-engaged patients.
3. 03The analysis was complete-case and per-protocol, drawn from 39,220 initiators, with engagement and outcome assessed concurrently, so causal direction is unresolved.

From the source

Digital Engagement Phenotypes and 6-Month Weight Loss in a Tirzepatide-Supported Digital Weight-Loss Program: A Retrospective Cohort Study

Medicina (Kaunas, Lithuania) · 2026 Aug 27 · Talay L, Xu C, Hom J et al.